Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
183,558,579
-
Total 13F shares
-
121,963,764
-
Share change
-
+6,489,409
-
Total reported value
-
$514,346,608
-
Put/Call ratio
-
47%
-
Price per share
-
$4.22
-
Number of holders
-
178
-
Value change
-
+$45,998,596
-
Number of buys
-
89
-
Number of sells
-
58
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) as of Q3 2022
As of 30 Sep 2022,
HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) was held by
178 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
121,963,764 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, Deep Track Capital, LP, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, JPMORGAN CHASE & CO, GREAT POINT PARTNERS LLC, and ArrowMark Colorado Holdings LLC.
This page lists
178
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.